Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Understanding treatment resistance and the neuroendocrine phenotype in prostate cancer

Understanding treatment resistance and the neuroendocrine phenotype in prostate cancer

Información

Fecha: 26/09/2019
Hora 12:00
Lugar: CNIO Auditorium
Conferenciante Himisha Beltrán
Procedencia Dana Farber Cancer Institute, Boston, US
Invitado por David Olmos, Prostate Cancer Clinical Research Unit, Clinical Research Programme
Entrada libre hasta completar aforo

Subir